Table 4 Analysis of hepatic and extrahepatic complications of patients treated for HCV.
From: A cascade of care analysis on the elimination of hepatitis C from public hospitals in Madrid
Haemodialysis (n = 44) n (%) | HIV (n = 231) n (%) | PWID (n = 103) n (%) | HHD (n = 3) n (%) | ALD (n = 277) n (%) | Transplant (n = 156) n (%) | Total (n = 814) n (%) | |
|---|---|---|---|---|---|---|---|
Hepatic complications | |||||||
Jaundice | 0 (0.0) | 7 (3.0) | 2 (1.9) | 0 (0.0) | 4 (1.4) | 11 (7.1) | 24 (2.9) |
Hepatic encephalopathy | 2 (4.5) | 3 (1.3) | 0 (0.0) | 0 (0.0) | 8 (2.9) | 15 (9.6) | 28 (3.4) |
Ascites | 6 (13.6) | 11 (4.8) | 2 (1.9) | 0 (0.0) | 21 (7.6) | 53 (34.0) | 93 (11.4) |
Variceal bleeding | 2 (4.5) | 4 (1.7) | 0 (0.0) | 0 (0.0) | 10 (3.6) | 20 (12.8) | 36 (4.4) |
HCC | 2 (4.5) | 7 (3.0) | 0 (0.0) | 0 (0.0) | 19 (6.9) | 68 (43.6) | 95 (11.6) |
Decompensated cirrhosis | 5 (11.4) | 10 (4.3) | 1 (1.0) | 0 (0.0) | 44 (15.9) | 78 (50.0) | 135 (16.6) |
Extrahepatic complications | 1 (2.3) | 11 (4.8) | 1 (1.0) | 0 (0.0) | 5 (1.8) | 1 (0.6) | 19 (2.3) |
Cryoglobulinemia | |||||||
Other vasculitis | 0 (0.0) | 1 (0.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (1.3) | 3 (0.4) |
Arthritis/arthralgia | 2 (4.5) | 1 (0.4) | 0 (0.0) | 0 (0.0) | 1 (0.4) | 0 (0.0) | 4 (0.5) |
Monoclonal gammopathy | 1 (2.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.4) | 1 (0.6) | 3 (0.4) |
T2DM | 5 (11.4) | 6 (2.6) | 2 (1.9) | 0 (0.0) | 24 (8.7) | 17 (10.9) | 54 (6.6) |
Renal impairment | 13 (29.5) | 3 (1.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 10 (6.4) | 26 (3.2) |
Mental health issues | 0 (0.0) | 10 (4.3) | 2 (1.9) | 0 (0.0) | 13 (4.7) | 1 (0.6) | 26 (3.2) |
Other | 2 (4.5) | 14 (6.1) | 1 (1.0) | 0 (0.0) | 10 (3.6) | 3 (1.9) | 30 (3.7) |
